• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

European countries vie to host drug agency after Brexit

April 11, 2017 By Sarah Faulkner

European countries vie to host drug agency after BrexitThe European Medicines Agency said it has heard from 21 countries that want to host the London-based regulator once Britain leaves. The EMA is preparing to leave its headquarters as a result of Brexit and the agency’s executive director reportedly said they are hoping for a quick decision on its new location.

The location will be finalized by EU heads of state at the European Council. The EMA told Reuters that representatives from countries ranging from Austria, Croatia, Denmark, Germany, Italy, Sweden and others have expressed interest in hosting the agency.

The other large EU body in London, the European Banking Authority, is also slated relocate in the wake of Brexit.

The EMA is responsible for the EU drug approval process. Much like the FDA, the agency also oversees the safety of medicines once they hit the market. The group has nearly 900 employees and an annual budget of 322 million euros ($340 million).

The EMA is the largest EU institution in Britain, which is likely why 21 of the 27 countries that will form the EU once Britain leaves have expressed interest in hosting the agency.

The EMA said it doesn’t know if all of those countries would move forward with a formal bid. Poland, which was tipped as being among the countries keen to host the agency, has not been in touch to declare an interest.

Material from Reuters was used in this report.

Filed Under: Featured, Pharmaceuticals, Regulatory/Compliance, Wall Street Beat

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS